Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Vertex inches closer to acute pain market as FDA accepts VX-548
Vertex is inching closer to bringing a non-opioid pain med to market, with the FDA accepting an NDA submission for VX-548, now dubbed suzetrigine.
Gabrielle Masson
Apr 18, 2024 10:50am
AACR: Biotechs emerge frostbitten from 'nuclear winter'
Apr 18, 2024 10:25am
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
Biopharma M&A more than doubled in Q1 compared to a year ago
Apr 18, 2024 9:46am
Sponsored
Cognizant & Takeda Discuss Digital Transformation in Lifescience
Feb 12, 2024 8:00am
AbbVie-bound Cerevel reports phase 3 Parkinson's victory
Apr 18, 2024 8:34am